Navigation Links
The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
Date:10/15/2007

BOSTON, Oct. 15 /PRNewswire/ -- The Liver Meeting is the premier meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies.

Approximately 10 percent of Americans have some form of liver disease, and the diseases strike disproportionately among certain populations but mostly regardless of lifestyle choices. There are now numerous treatments for both hepatitis B and C, whereas liver cancer is one of the few cancers growing in incidence.

An AASLD President's press conference highlighting key abstracts and issues presented at the Liver Meeting is scheduled for Saturday, November 3 at 4:00 p.m.

The approximately 1500 abstracts to be presented will be available to members of the press at our Web site (http://www.aasld.org), including almost 200 abstracts that will be presented in oral sessions.

Boston, MA - November 2-6, 2007

-- Poster Presentations: November 3-6

-- Oral Presentations: November 4-6

Please contact AASLD at 703-299-9766 for information about the above presentations, or to receive any additional information about The Liver Meeting -- or visit our Web site at http://www.aasld.org.

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.


'/>"/>
SOURCE American Association for the Study of Liver Diseases
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. NameProtect releases annual list of top trademarkers
2. Doyle says new contracts saving state more than $16 million annually
3. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
4. Annual Bioethics Forum to explore genetic testing
5. Annual Conference Honors Tech Grant Winners
6. AG accuses BioCATT of violating meetings law
7. VC trends, company progress discussed at Mason Wells portfolio meeting
8. Beware the Dreaded Off-Site Technology Meeting
9. A disgusting video: U.S. companies sell out Americans
10. Northwestern Mutual, American Family make Computerworlds best IT workplaces
11. Brazilian bio-industry should impress American investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
(Date:3/22/2017)... ... ... Premier executive recruitment firm, Slone Partners, is proud to have been named a Top ... Hunt Scanlon Media is one of the most respected life science publications in the ... sector. , “It is a great honor for Slone Partners to be part of ...
(Date:3/22/2017)... , ... March 21, 2017 , ... The Conference Forum ... (CMO Summit) to be held on May 10-11, 2017, at the Colonnade Hotel in ... specifically for Chief Medical Officer peer-to-peer learning, benchmarking and support. , “The Chief Medical ...
(Date:3/22/2017)... and PETACH TIKVAH, Israel , March ... a leading developer of adult stem cell technologies for ... Chief Executive Officer, will provide an update on new ... nd Annual Neuroscience Biopartnering and Investment Forum, being ... York Academy of Sciences. ...
Breaking Biology Technology:
(Date:3/6/2017)... , March 6, 2017 ... sales technology, today announced Predictive Sales Coach TM ... infusing actionable sales intelligence into Salesforce. This unique ... enable their sales organizations with deep knowledge of ... allow for intelligent engagement. Predictive Sales Coach extends ...
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
Breaking Biology News(10 mins):